Here's your summary from Ozempic, Wegovy Really Good Value: Novo Nordisk CEO (https://www.youtube.com/watch?v=odPSZbFltkE) on the Bloomberg Television channel:

**TLDR:** Novo Nordisk CEO discusses the value of their medicines in addressing chronic diseases like diabetes and obesity, highlighting the importance of investing in prevention to reduce healthcare costs.

1. Novo Nordisk's medicines provide value to both individual patients and healthcare systems by addressing chronic diseases like diabetes and obesity.

2. The World Obesity Federation predicts a significant cost burden to society by 2035 due to the increasing prevalence of obesity, emphasizing the need for preventative measures.

3. With more competitors entering the market, pricing for these medicines may decrease over time, making investment decisions crucial for the company's future success.

#finance #tradfi #markets #stocks #stockmarket #bloomberg #macro nostr:npub1849ntz6s6gxrunv9tunnlurvfx7xk0mwvtzz4m2y7fu8gt7408dqsl0qen nostr:npub1tlvvdgm4csch9x3m0r3qsrll7zsaccl49c4gdz5qz9g3jz33l92ss4gp7z